Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. VINGE ADVISES FYNDIQ IN CONNECTION WITH INVESTMENT BY NORTHZONE AND INDUSTRIFONDEN
Mandate

VINGE ADVISES FYNDIQ IN CONNECTION WITH INVESTMENT BY NORTHZONE AND INDUSTRIFONDEN

November 07, 2014

Vinge has advised Fyndiq in connection with the company’s capital raising of SEK 150 million from Northzone and Industrifonden. Fyndiq (www.fyndiq.se) is an online shopping site linking e-traders and consumers. Since the company was formed in 2010, it has helped thousands of e-traders to sell their products to millions of consumers.

Vinge’s team consisted of responsible partner Jonas Bergström together with, among others, associates Joacim Rydergård, Gustav Jönsson, Ulrika Andersson and Andrea Jägerstad as well as paralegal Pernilla Warg.

Related

Vinge advises Trianon in connection with directed share issue and tender offer for subordinated sustainable capital securities

 Vinge advises Fastighets Aktiebolaget Trianon (publ) in connection with a directed share issue of SEK 184 million and a tender offer for outstanding subordinated perpetual floating rate callable sustainable capital securities.
April 19, 2024

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

 Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024